EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Nutraceutical COMP-4 confers protection against endothelial dysfunction through the eNOS/iNOS-NO-cGMP pathway

Monica G Ferrini, Andrea Abraham, Revecca Millán iD, Leslie Graciano, Sriram V Eleswarapu iD, Jacob Rajfer

PLOS ONE · 2025

DOI: 10.1371/journal.pone.0316798 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS ONE, 2025. Verfasst von Monica G Ferrini und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Health and Life Sciences, Charles R. Drew University of Medicine and Science, Los Angeles, California, United States of America. Hauptthemen laut MEDLINE: Nitric Oxide Synthase Type III, Dietary Supplements, Nitric Oxide, Cyclic GMP. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIMHD NIH HHS, National Institute on Minority Health and Health Disparities, Peter A. Morton Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The nutraceutical COMP-4 –consisting of L-citrulline, ginger extract, and herbal components Paullinia cupana and muira puama–has been shown previously to stimulate the production of nitric oxide (NO) in a variety of tissue types. We hypothesized that COMP-4 may have a protective, stimulatory effect on the vascular endothelial cell. Human umbilical arterial endothelial cells were incubated for 24 hours with or without COMP-4 and, to replicate impairment of endothelial function, co-incubated with or without H 2 O 2 . NO intracellular content, nitrite formation and cGMP content in culture media, nitric oxide synthase (NOS) isoforms and mRNA content, pro-inflammatory cytokines, and PAI-1 expression and activity were measured. COMP-4 increased endothelial cell production of NO and cGMP and the expression of both endothelial NOS (eNOS) and inducible NOS (iNOS), in tandem with a reduction in cytokine expression and activity of PAI-1. Co-incubation of COMP-4 with H 2 O 2 reversed detrimental effects of H 2 O 2 on endothelial function, evidenced by improvement in NO availability and abrogation of the pro-inflammatory milieu. These results suggest that COMP-4 exerts a stimulatory effect on endothelial cell eNOS and iNOS to increase NO bioavailability, leading to a reduction in pro-inflammatory cytokines, particularly the prothrombotic PAI-1.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Nitric Oxide Synthase Type IIIDietary SupplementsNitric OxideCyclic GMPNitric Oxide Synthase Type IISignal TransductionEndothelial CellsCitrullineEndothelium, VascularHumansHydrogen PeroxidePlasminogen Activator Inhibitor 1CytokinesHuman Umbilical Vein Endothelial Cells

Substanzen

Nitric Oxide Synthase Type IIINitric OxideCyclic GMPNitric Oxide Synthase Type IIHydrogen PeroxideNOS3 protein, humanCitrullinePlasminogen Activator Inhibitor 1CytokinesNOS2 protein, human

Autor:innen und Institutionen

  • Department of Health and Life Sciences, Charles R. Drew University of Medicine and Science, Los Angeles, California, United States of America.
  • Department of Urology, David Geffen School of Medicine at UCLA, Los Angeles, California, United States of America.

ORCID-Profile: Revecca Millán, Sriram V Eleswarapu

Förderung

  • NIMHD NIH HHS
  • National Institute on Minority Health and Health Disparities
  • Peter A. Morton Foundation

Zitieren

APA

Ferrini, M. G., Abraham, A., Millán, R., Graciano, L., Eleswarapu, S. V., & Rajfer, J. (2025). Nutraceutical COMP-4 confers protection against endothelial dysfunction through the eNOS/iNOS-NO-cGMP pathway. PLOS ONE. https://doi.org/10.1371/journal.pone.0316798

Vancouver

Ferrini MG, Abraham A, Millán R, Graciano L, Eleswarapu SV, Rajfer J. Nutraceutical COMP-4 confers protection against endothelial dysfunction through the eNOS/iNOS-NO-cGMP pathway. PLOS ONE. 2025. doi:10.1371/journal.pone.0316798

BibTeX
@article{Ferrini2025,
  author = {Ferrini, Monica G and Abraham, Andrea and Millán, Revecca and Graciano, Leslie and Eleswarapu, Sriram V and Rajfer, Jacob},
  title = {Nutraceutical COMP-4 confers protection against endothelial dysfunction through the eNOS/iNOS-NO-cGMP pathway},
  journal = {PLOS ONE},
  year = {2025},
  doi = {10.1371/journal.pone.0316798}
}
Kostenlos starten →